Coverage
-
September 03, 2020
A Pennsylvania federal judge on Thursday issued a preliminary injunction blocking Boehringer Ingelheim Pharmaceuticals from conveying in training materials for its sales representatives false or misleading information about rival GlaxoSmithKline LLC's inhalers for patients with chronic obstructive pulmonary disease.
1 other articles on this case.
View all »